No impact to previous guidance.In some ways this is positive as Phase 3 trials cost a lot to run.Csl can concentrate on making the AstraZeneca/Oxford vaccine instead.
Ann: Update on UQ-CSL v451 COVID-19 Vaccine, page-2
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$282.08 |
Change
-4.870(1.70%) |
Mkt cap ! $136.4B | |||
| Open | High | Low | Value | Volume |
| $284.41 | $285.00 | $281.69 | $87.45M | 305.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 61 | $282.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $282.08 | 54 | 7 |
View Market Depth
| Last trade - 14.05pm 01/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |